Literature DB >> 28809092

Particle Targeting in Complex Biological Media.

Qiong Dai1, Nadja Bertleff-Zieschang1, Julia A Braunger1, Mattias Björnmalm1, Christina Cortez-Jugo1, Frank Caruso1.   

Abstract

Over the past few decades, nanoengineered particles have gained increasing interest for applications in the biomedical realm, including diagnosis, imaging, and therapy. When functionalized with targeting ligands, these particles have the potential to interact with specific cells and tissues, and accumulate at desired target sites, reducing side effects and improve overall efficacy in applications such as vaccination and drug delivery. However, when targeted particles enter a complex biological environment, the adsorption of biomolecules and the formation of a surface coating (e.g., a protein corona) changes the properties of the carriers and can render their behavior unpredictable. For this reason, it is of importance to consider the potential challenges imposed by the biological environment at the early stages of particle design. This review describes parameters that affect the targeting ability of particulate drug carriers, with an emphasis on the effect of the protein corona. We highlight strategies for exploiting the protein corona to improve the targeting ability of particles. Finally, we provide suggestions for complementing current in vitro assays used for the evaluation of targeting and carrier efficacy with new and emerging techniques (e.g., 3D models and flow-based technologies) to advance fundamental understanding in bio-nano science and to accelerate the development of targeted particles for biomedical applications.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Keywords:  active targeting; carrier design; drug delivery; nanoparticles; protein corona

Mesh:

Substances:

Year:  2017        PMID: 28809092     DOI: 10.1002/adhm.201700575

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  14 in total

Review 1.  Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics.

Authors:  Elham Hatami; Meena Jaggi; Subhash C Chauhan; Murali M Yallapu
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-05-31       Impact factor: 10.680

Review 2.  Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases.

Authors:  Kye S Kim; Chul Gyu Song; Peter M Kang
Journal:  Antioxid Redox Signal       Date:  2018-01-30       Impact factor: 8.401

Review 3.  Micro/Nanosystems for Magnetic Targeted Delivery of Bioagents.

Authors:  Francesca Garello; Yulia Svenskaya; Bogdan Parakhonskiy; Miriam Filippi
Journal:  Pharmaceutics       Date:  2022-05-26       Impact factor: 6.525

Review 4.  Peptidylglycine α-amidating monooxygenase as a therapeutic target or biomarker for human diseases.

Authors:  David J Merkler; Aidan J Hawley; Betty A Eipper; Richard E Mains
Journal:  Br J Pharmacol       Date:  2022-02-28       Impact factor: 9.473

Review 5.  Physical stimuli-responsive vesicles in drug delivery: Beyond liposomes and polymersomes.

Authors:  Ulrike Kauscher; Margaret N Holme; Mattias Björnmalm; Molly M Stevens
Journal:  Adv Drug Deliv Rev       Date:  2018-10-25       Impact factor: 15.470

6.  Dual-Responsive Core Crosslinking Glycopolymer-Drug Conjugates Nanoparticles for Precise Hepatocarcinoma Therapy.

Authors:  Jing Wu; Jiayi Yuan; Baotong Ye; Yaling Wu; Zheng Xu; Jinghua Chen; Jingxiao Chen
Journal:  Front Pharmacol       Date:  2018-07-17       Impact factor: 5.810

Review 7.  Hide and Seek: Nanomaterial Interactions With the Immune System.

Authors:  Bengt Fadeel
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

Review 8.  Engineered Polymeric Materials for Biological Applications: Overcoming Challenges of the Bio-Nano Interface.

Authors:  Joshua D Simpson; Samuel A Smith; Kristofer J Thurecht; Georgina Such
Journal:  Polymers (Basel)       Date:  2019-09-02       Impact factor: 4.329

9.  Unraveling the In Vivo Protein Corona.

Authors:  Johanna Simon; Gabor Kuhn; Michael Fichter; Stephan Gehring; Katharina Landfester; Volker Mailänder
Journal:  Cells       Date:  2021-01-12       Impact factor: 6.600

10.  Antibody-Functionalized Carnauba Wax Nanoparticles to Target Breast Cancer Cells.

Authors:  Banu Iyisan; Johanna Simon; Yuri Avlasevich; Stanislav Baluschev; Volker Mailaender; Katharina Landfester
Journal:  ACS Appl Bio Mater       Date:  2022-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.